A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma - Concepedia

Concepedia

Publication | Open Access

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma

DOI Full Paper Access

18

Citations

47

References

2023

Year

Nathaniel Dasyam, Katrina Sharples, Catherine Barrow, Ying Huang, Evelyn Bauer, Brigitta Mester, Catherine Wood, Astrid Authier-Hall, Marina Dzhelali, Tess Ostapowicz,

Cancer Immunology Immunotherapy

References

	Year	Citations

Page 1